Stickers Promise a Painless Mode of Measles Vaccine Delivery

The outcomes of the first clinical trial demonstrate the safety and efficacy of the measles-rubella (MR) vaccination to adults and infants as young as 9 months.

Related Keywords

, Needles , Ainless Sticker , Microarray Technology , Measles Rubella Mr Vaccine , Clinical Trial ,